| scholarly article | Q13442814 |
| P2093 | author name string | Phuapradit P | |
| Kaojarern S | |||
| Mokkhavesa C | |||
| Supmonchai K | |||
| P2860 | cites work | Penetration of pyrazinamide into the cerebrospinal fluid in tuberculous meningitis | Q34068408 |
| Determination of drug susceptibility of mycobacteria to pyrazinamide in 7H10 agar | Q34700960 | ||
| Pyrazinamide and other drugs in tuberculous meningitis | Q48637626 | ||
| Cerebrospinal fluid pyrazinamide concentrations in children with tuberculous meningitis | Q68474511 | ||
| Treatment of tuberculous meningitis: role of short-course chemotherapy | Q69409105 | ||
| Pyrazinamide in treatment of tuberculous meningitis | Q69608928 | ||
| Hepatic toxicity during chemotherapy for severe tuberculosis meningitis | Q69900544 | ||
| Killing of macrophage-ingested mycobacteria by rifampicin, pyrazinamide, and pyrazinoic acid alone and in combination | Q69974250 | ||
| Methods for the estimation of pyrazinamide and pyrazinoic acid in body fluids | Q71212245 | ||
| Cerebrospinal fluid pharmacokinetics of the antituberculosis drugs | Q93645814 | ||
| P433 | issue | 1 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | meningitis | Q48143 |
| cerebrospinal fluid | Q54196 | ||
| pyrazinamide | Q417571 | ||
| tuberculous meningitis | Q3854687 | ||
| P304 | page(s) | 81-82 | |
| P577 | publication date | 1990-01-01 | |
| P1433 | published in | Journal of Neurology, Neurosurgery and Psychiatry | Q1599804 |
| P1476 | title | The blood/cerebrospinal fluid partitioning of pyrazinamide: a study during the course of treatment of tuberculous meningitis | |
| P478 | volume | 53 |
| Q37133651 | Central nervous system tuberculosis: pathogenesis and clinical aspects |
| Q37780003 | Cerebrospinal fluid concentrations of antituberculosis agents in adults and children |
| Q38100704 | Clinical pharmacokinetics of antibacterials in cerebrospinal fluid. |
| Q34125176 | Isoniazid resistance and death in patients with tuberculous meningitis: retrospective cohort study |
| Q48369007 | Pharmacokinetic optimisation of the treatment of bacterial central nervous system infections |
| Q28074247 | Six months therapy for tuberculous meningitis |
| Q36264331 | The management of tuberculous meningitis |
| Q33997764 | Treatment of tuberculous infection and disease in children: the North American perspective |
Search more.